Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $970.38M.
ENTERPRISE VALUE (EV)
$970.38M
Replimune Group, Inc.
Market Cap
$1.10B
Enterprise Value (EV)
$970.38M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Replimune Group, Inc. (REPL) | $1.10B | $970.38M |
| OPKO Health, Inc. (OPK)vs › | $1.10B | $1.19B |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.09B | $927.75M |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | $992.57M |
| STAAR Surgical Company (STAA)vs › | $1.11B | $996.15M |
| IRadimed Corporation (IRMD)vs › | $1.08B | $1.02B |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.12B | $1.80B |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.12B | $874.76M |
| Harrow Health, Inc. (HROW)vs › | $1.13B | $1.34B |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | $1.60B |
Market Cap
$1.10B
Total Debt
$83.31M
Cash
$209.02M
Enterprise Value
$970.38M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
